204 related articles for article (PubMed ID: 32134149)
1. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.
Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS
J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149
[TBL] [Abstract][Full Text] [Related]
2. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
3. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.
Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A
Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508
[TBL] [Abstract][Full Text] [Related]
4. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.
Zimmermann N; McBride ML; Yamada Y; Hudson SA; Jones C; Cromie KD; Crocker PR; Rothenberg ME; Bochner BS
Allergy; 2008 Sep; 63(9):1156-63. PubMed ID: 18699932
[TBL] [Abstract][Full Text] [Related]
5. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
Tateno H; Crocker PR; Paulson JC
Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
[TBL] [Abstract][Full Text] [Related]
6. Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death
Carroll DJ; Cao Y; Bochner BS; O'Sullivan JA
Front Immunol; 2021; 12():737988. PubMed ID: 34721399
[TBL] [Abstract][Full Text] [Related]
7. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen.
Mao H; Kano G; Hudson SA; Brummet M; Zimmermann N; Zhu Z; Bochner BS
PLoS One; 2013; 8(6):e68143. PubMed ID: 23840825
[TBL] [Abstract][Full Text] [Related]
9. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.
Kiwamoto T; Katoh T; Evans CM; Janssen WJ; Brummet ME; Hudson SA; Zhu Z; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2015 May; 135(5):1329-1340.e9. PubMed ID: 25497369
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
[TBL] [Abstract][Full Text] [Related]
11. Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.
Suzukawa M; Miller M; Rosenthal P; Cho JY; Doherty TA; Varki A; Broide D
J Immunol; 2013 Jun; 190(12):5939-48. PubMed ID: 23677475
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
13. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
[TBL] [Abstract][Full Text] [Related]
14. Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation.
Kiwamoto T; Brummet ME; Wu F; Motari MG; Smith DF; Schnaar RL; Zhu Z; Bochner BS
J Allergy Clin Immunol; 2014 Jan; 133(1):240-7.e1-3. PubMed ID: 23830412
[TBL] [Abstract][Full Text] [Related]
15. Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
[TBL] [Abstract][Full Text] [Related]
16. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis.
Rubinstein E; Cho JY; Rosenthal P; Chao J; Miller M; Pham A; Aceves SS; Varki A; Broide DH
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):409-16. PubMed ID: 21970996
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
[TBL] [Abstract][Full Text] [Related]
18. Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells.
Cao Y; Rische CH; Bochner BS; O'Sullivan JA
Front Immunol; 2023; 14():1283370. PubMed ID: 37928558
[TBL] [Abstract][Full Text] [Related]
19. Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model.
McMillan SJ; Richards HE; Crocker PR
Immunol Lett; 2014 Jul; 160(1):11-16. PubMed ID: 24698729
[TBL] [Abstract][Full Text] [Related]
20. Divergent Siglec-F(eights) of mouse and human eosinophil death.
Jacobsen EA
J Leukoc Biol; 2020 Jul; 108(1):9-11. PubMed ID: 32557797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
